UniCredit to Take Over CNP Assurances and Allianz's Italy Life Bancassurance Units
By Elena Vardon
UniCredit is buying major stakes in the Italian life bancassurance businesses of France's CNP Assurances and Germany's Allianz, seeking to consolidate the sector in the country.
The Italian bank, who has long-standing partnerships with both groups, on Wednesday said that it will exercise its rights to acquire a 51% stake in CNP UniCredit Vita from the French insurer as well as Allianz's 50% stake in UniCredit Allianz Vita.
UniCredit will hold 100% of both businesses upon deal closing, which is expected to close in 2025, subject to authorizations.
The purchase price for each stake will be determined with each party based on their original agreements, it said, adding that the deals will be cash funded.
"The internalization of life bancassurance factories in Italy will allow UniCredit to accelerate growth in a commission-focused sector with attractive profitability," UniCredit said.
Alessandro Santoliquido, who oversees the insurance business at the group level, will lead the newly created bancassurance division and the two companies, it added.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
September 25, 2024 02:46 ET (06:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk